BioPharma Credit (BPCR)

Index:

FTSE 250

$ 0.94
   
  • Change Today:
    $0.00
  • 52 Week High: $0.9
  • 52 Week Low: $0.8
  • Currency: US Dollars
  • Shares Issued: 1,126.22m
  • Volume: 137,376
  • Market Cap: $1,058.64m
  • RiskGrade: 32
  • Beta: 0.00

BPCR Overview

BioPharma Credit plc provides investors with an opportunity to gain exposure to the fast growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. BioPharma Credit’s primary objective is to generate predictable income for shareholders over the long term.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 7.5% 0.0%
Div Cover 1.4 n/a
Op Mrgn 80.4% n/a
ROCE 9.8%  
Latest F'cast
P/E 9.4 n/a
PEG n/a n/a
Pr/Revenue 7.5 n/a
Pr/Book 0.9  
Latest F'cast
Revenue -6.0% n/a
PBT -8.1% n/a
EPS -1.4% n/a
DPS n/a n/a

BPCR Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 127.63 108.73 7.91¢ 12.2 0.3 +36% 7.00¢ 7.2%
31-Dec-22 212.22 176.39 12.93¢ 7.3 0.1 +64% 7.00¢ 7.4%
31-Dec-23 155.36 132.40 10.11¢ 8.3 n/a -22% 7.00¢ 8.3%
31-Dec-24 148.63 122.27 10.00¢ 8.8 n/a -1% 7.00¢ 7.9%
31-Dec-25 139.75 112.33 9.86¢ 9.3 n/a -1% 7.00¢ 7.6%

BPCR Company Announcements

STATEMENT RE COLLEGIUM PREPAYMENT 30-Dec-2025 13:32 RNS

BPCR ShareCast News

STATEMENT RE COLLEGIUM PREPAYMENT 30-Dec-2025 ShareCast
BioPharma Credit puts $165m into pharma firm Col... 07-Feb-2020 ShareCast
BioPharma Credit pours cash into US firms Epizym... 13-Nov-2019 ShareCast

Latest BPCR Director Deals

Traded Action Notifier PriceAmountValue
25-Mar-26 Buy Sapna Shah $0.94 42,500 $39,950.00
23-Mar-26 Buy Dividends Harry Abraham Hyman 70.13p 137 £116.51

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

BPCR Market Data

Currency US Dollars
Share Price $ 0.94
Change Today $ 0.00
% Change 0.00 %
52 Week High $0.9
52 Week Low $0.8
Volume 137,376
Shares Issued 1,126.22m
Market Cap $1,058.64m
Beta 0.00
RiskGrade 32

BPCR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

BPCR Dividends

  Latest Previous
  Special 4th Interim
Ex-Div 19-Feb-26 19-Feb-26
Paid 20-Mar-26 20-Mar-26
Amount 1.45¢ 1.75¢

Trades for 21-Apr-2026

Time Volume / Share Price
10:48 6,012 @ $0.94
10:48 6,012 @ $0.94
10:41 98 @ $0.94
10:41 300 @ $0.94
10:41 6 @ $0.94

BPCR Key Personnel

Chair Harry Abraham Hyman

Top of Page